BE study design issue [Design Issues]

posted by Dr_Dan  – 2019-12-18 15:04 (511 d 13:39 ago) – Posting: # 20992
Views: 2,198

Hi John
if the recommended dosage regimen of the IR as per product monograph IR is to be given every 4 hrs then this means that higher doses have either a safety issue or the dose/effect relationship is in disfavor of higher doses. In this case AUC alone does not matter. Consequently, a regulatory body will reject the study
Hope this helps

Kind regards and have a nice day

Complete thread:

 Admin contact
21,457 posts in 4,485 threads, 1,512 registered users;
online 8 (0 registered, 8 guests [including 2 identified bots]).
Forum time: Thursday 05:44 CEST (Europe/Vienna)

Nothing in the world is more dangerous
than sincere ignorance
and conscientious stupidity.    Martin Luther King, Jr.

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz